Kratom Research Institute

Research · 2026-03-01

Florida Case-Control Study: Pure Mitragynine Fatalities Show 14-Fold Higher Blood Concentrations Than Co-Exposure Deaths

Source: Journal of Analytical Toxicology

Why it matters

The most comprehensive U.S. autopsy study on kratom deaths to date identifies distinct toxicological profiles between fatal overdoses caused solely by mitragynine versus those involving polysubstance co-exposure — critical data for forensic pathologists, clinicians, and policymakers evaluating kratom's risk profile.

The big picture

Most prior research linking kratom to deaths involved polysubstance cases where fentanyl or other opioids were present. This new five-year Florida study separates "mitragynine-induced fatalities" (no other toxic substance present) from "mitragynine-associated deaths" (co-exposures present). Researchers found that pure mitragynine deaths are characterized by very high blood concentrations and specific autopsy findings, while the majority of kratom-involved deaths result from drug combinations, particularly fentanyl.

Key findings

What they say

Researchers concluded: "Mitragynine toxicity accounts for a notable number of deaths" and described a "concentration-dependent association with fatal toxicity" at blood levels averaging 2,486 µg/L in pure mitragynine cases — roughly 14 times higher than co-exposure deaths.

Bottom line

Pure mitragynine can be lethal at very high blood concentrations, but the vast majority of kratom-involved deaths in Florida involved fentanyl or other co-substances — an important distinction for forensic and clinical interpretation of toxicology results.